Clinical Trial Update: Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the addition of AZD1390 to radiation therapy for newly diagnosed pediatric high-grade gliomas, including diffuse midline glioma and D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Astrocytoma
• Diffuse Intrinsic Pontine Glioma
• Diffuse Midline Glioma
• Glioblastoma
• Malignant Glioma

Drugs mentioned

• AZD1390

Snippet

Sponsor: Children's Oncology Group | Conditions: Childhood Astrocytoma, Childhood Diffuse Intrinsic Pontine Glioma | Phase 1 | Status: RECRUITING